Federation Des Caisses Desjardins Du Quebec Celldex Therapeutics, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 1,544 shares of CLDX stock, worth $37,596. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,544
Previous 1,534
0.65%
Holding current value
$37,596
Previous $56,000
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CLDX
# of Institutions
206Shares Held
67.3MCall Options Held
1.69MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$225 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$94.2 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$84.2 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$81.1 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.14B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...